investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Toxicity Monitoring on Phase III Trials with Administrative Data

Richard Aplenc

1 Collaborator(s)

Funding source

National Cancer Institute (NIH)

No posts

Related projects

Jeffrey S Miller

NK Cells, their Receptors and Unrelated Donor Transplant

Leukaemia

Hematology and hematologic malignancies

Rainer F Storb

Hematopoietic Chimerism after Stem Cell Allografts

Leukaemia

Hematology and hematologic malignancies

Susan L Slager

Genetic Epidemiology Of Chronic Lymphocytic Leukemia

Leukaemia

Hematology and hematologic malignancies

Kenneth C Anderson

Specialized Program of Research Excellence (SPORE) in Multple Myeloma

Leukaemia

Hematology and hematologic malignancies

Christopher I Li

Pediatric Oncology Research Training Program

Leukaemia

Pediatric oncology or childhood cancer

Reuben Kapur

Role of p21 Activated Kinase in Leukemogenesis

Leukaemia

Hematology and hematologic malignancies

Ravi Bhatia

Microenvironmental Regulation of Leukemia Stem Cells

Leukaemia

Hematology and hematologic malignancies

Ronald Hoffman

A New Murine Model for MPN: Pathology and Therapy of NF-E2 Overexpression

Leukaemia

Hematology and hematologic malignancies

Theresa E Hahn

Genetic susceptibility to acute lymphocytic and myeloid leukemia

Leukaemia

Pediatric oncology or childhood cancer